Replies to post #33642 on Lifeline Biotechnologies Inc (LLBO)

[GetSeriousOK]

It's not called the iTBra any more. There is no iTBra.

the device is called the Cyrcadia Breast Monitor and it's on the shelf gathering dust. Acropolis can't do anything about it. They don't tweet about the device because LLBO doesn't have anything to do with the device.

Jimmy Holmes is the only person who can do anything with the Cyrcadia Breast Monitor and he's content doing nothing but sending BS emails to investors.

Acropolis will probably schedule a Shareholders Meeting before August 17th because on that day they have to go before Judge Jones and tell him how they are complying with the rules of being a Custodian and one of those rules is to schedule a Shareholders Meeting ASAP. If Holmes isn't completely senile, he should attend the courtroom in IN PERSON and complain about how:

1. Acropolis was lying when they said the stock would be suspended if not current before June 30th;

2. Acropolis hasn't scheduled the Shareholders Meeting yet;

3. Acropolis tried to get one of the other three zombies, KAST, "Pink Current" but succeeded only in getting it "Pink Limited Information" which implies they are incompetent Custodians. OTCIQ is backlogged but that's no excuse for failing to get that ticker to "Pink Current."

4. LLBO will be limited on TDA as of the 17th - TDA customers won't be able to buy the stock on that court date - that's not a sign of a good Custodian.

Problem is, I suspect Holmes is pretty much completely senile. I don't think he understands how he lost LLBO. Maybe he doesn't care since LLBO wasn't making him any money. Whatever.

I think investors need to keep in mind that LLBO, KAST, and KATX are poster children for the exact reason the SEC amended Rule 15c2-11 -- to stop fraud and abuse in the case of reverse mergers into shell companies.
https://www.sec.gov/rules/final/2020/33-10842.pdf

Shell companies can be used for valid reasons; however, the Commission has noted that unregistered reverse mergers between privately held companies and publicly traded shell companies commonly are used to develop a market for the merged entity’s securities, often as part of a
pump-and-dump scheme.